# Paclitaxel and Irinotecan in Advanced Gastric Cancer

> **NCT01136031** · PHASE1,PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 42 (actual)

## Conditions studied

- Advanced Gastric Cancer

## Interventions

- **DRUG:** Paclitaxel and irinotecan

## Key facts

- **NCT ID:** NCT01136031
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-08
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136031, "Paclitaxel and Irinotecan in Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01136031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*